Published in BMC Bioinformatics on July 29, 2013
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med (2015) 2.07
Systems biology approaches for advancing the discovery of effective drug combinations. J Cheminform (2015) 0.90
Exploiting receptor tyrosine kinase co-activation for cancer therapy. Drug Discov Today (2016) 0.79
A diverse stochastic search algorithm for combination therapeutics. Biomed Res Int (2014) 0.78
Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition data. Bioinformatics (2015) 0.77
Integrating Domain Specific Knowledge and Network Analysis to Predict Drug Sensitivity of Cancer Cell Lines. PLoS One (2016) 0.77
An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancer. BMC Genomics (2015) 0.77
Improving Drug Sensitivity Prediction Using Different Types of Data. CPT Pharmacometrics Syst Pharmacol (2015) 0.75
Combination therapy design for maximizing sensitivity and minimizing toxicity. BMC Bioinformatics (2017) 0.75
Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine. Sci Rep (2016) 0.75
Inference of dynamic biological networks based on responses to drug perturbations. EURASIP J Bioinform Syst Biol (2014) 0.75
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78
A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol (2008) 14.74
Targeted cancer therapy. Nature (2004) 7.81
Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci U S A (2001) 7.51
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest (2009) 5.07
Translation of the Philadelphia chromosome into therapy for CML. Blood (2008) 4.74
Features of selective kinase inhibitors. Chem Biol (2005) 4.07
A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proc Natl Acad Sci U S A (2007) 3.78
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). Blood (2009) 3.40
Mouse xenograft models vs GEM models for human cancer therapeutics. Dis Model Mech (2008) 2.37
Molecular pathogenesis of osteosarcoma. DNA Cell Biol (2007) 2.31
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. Clin Cancer Res (2011) 2.27
PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer Drugs (2005) 2.09
Can we rationally design promiscuous drugs? Curr Opin Struct Biol (2006) 2.06
RNAi screen for rapid therapeutic target identification in leukemia patients. Proc Natl Acad Sci U S A (2009) 1.81
Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic data. PLoS Comput Biol (2009) 1.80
The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci U S A (2003) 1.69
Predicting in vitro drug sensitivity using Random Forests. Bioinformatics (2010) 1.59
Targeting targeted therapy. N Engl J Med (2004) 1.19
Ubiquitin, E6-AP, and their role in p53 inactivation. Pharmacol Ther (1998) 1.15
Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression. Mol Cell Biol (2000) 1.13
High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenes. Cancer (2011) 1.13
A kinase inhibition map approach for tumor sensitivity prediction and combination therapy design for targeted drugs. Pac Symp Biocomput (2012) 1.08
Molecularly targeted therapy: have the floodgates opened? Oncologist (2004) 1.08
p53 abnormalities in different subtypes of human sarcomas. Cancer Res (1993) 1.07
Molecular tumor profiling for prediction of response to anticancer therapies. Cancer J (2011) 0.96
Alteration of pRb/p16/cdk4 regulation in human osteosarcoma. Int J Cancer (1999) 0.92
Proteasome inhibition with bortezomib suppresses growth and induces apoptosis in osteosarcoma. Int J Cancer (2010) 0.89
ET-1 stimulates ERK signaling pathway through sequential activation of PKC and Src in rat myometrial cells. Am J Physiol Cell Physiol (2002) 0.88
ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells. J Bone Miner Res (1999) 0.87
Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science (2007) 8.07
Effective fiber hypertrophy in satellite cell-depleted skeletal muscle. Development (2011) 2.99
Virtual histology of transgenic mouse embryos for high-throughput phenotyping. PLoS Genet (2006) 2.45
Biomarker system for studying muscle, stem cells, and cancer in vivo. FASEB J (2009) 2.31
Sprouty1 regulates reversible quiescence of a self-renewing adult muscle stem cell pool during regeneration. Cell Stem Cell (2010) 2.03
Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell (2011) 1.96
Genetically separable functions of the MEC-17 tubulin acetyltransferase affect microtubule organization. Curr Biol (2012) 1.83
Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma. Proc Natl Acad Sci U S A (2014) 1.79
Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma. Pediatr Blood Cancer (2009) 1.72
Practical vessel imaging by computed tomography in live transgenic mouse models for human tumors. Mol Imaging (2005) 1.65
NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest (2013) 1.60
A Bayesian connectivity-based approach to constructing probabilistic gene regulatory networks. Bioinformatics (2004) 1.57
Overcoming autopsy barriers in pediatric cancer research. Pediatr Blood Cancer (2012) 1.47
MEC-2 is recruited to the putative mechanosensory complex in C. elegans touch receptor neurons through its stomatin-like domain. Curr Biol (2004) 1.47
Constitutive Notch activation upregulates Pax7 and promotes the self-renewal of skeletal muscle satellite cells. Mol Cell Biol (2012) 1.47
Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma. Cancer Res (2009) 1.37
Focal adhesion kinase signaling regulates the expression of caveolin 3 and beta1 integrin, genes essential for normal myoblast fusion. Mol Biol Cell (2009) 1.34
BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration. Dev Biol (2009) 1.11
Rhabdomyosarcoma: current challenges and their implications for developing therapies. Cold Spring Harb Perspect Med (2014) 1.10
Integrated analysis of transcriptomic and proteomic data. Curr Genomics (2013) 1.09
Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma. Mol Cancer Ther (2011) 1.07
Purinergic receptor stimulation reduces cytotoxic edema and brain infarcts in mouse induced by photothrombosis by energizing glial mitochondria. PLoS One (2010) 1.06
Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: a report from the Children's Oncology Group. Pediatr Blood Cancer (2006) 1.06
MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells. Stem Cells (2011) 1.04
Pax7 expressing cells contribute to dermal wound repair, regulating scar size through a β-catenin mediated process. Stem Cells (2011) 1.03
Images in cardiovascular medicine: Microscopic computed tomography-based virtual histology for visualization and morphometry of atherosclerosis in diabetic apolipoprotein e mutant mice. Circulation (2009) 1.03
Tbx22null mice have a submucous cleft palate due to reduced palatal bone formation and also display ankyloglossia and choanal atresia phenotypes. Hum Mol Genet (2009) 1.02
miR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR. Sci Signal (2013) 1.02
Immune competency of a hairless mouse strain for improved preclinical studies in genetically engineered mice. Mol Cancer Ther (2010) 1.00
A Postnatal Pax7 Progenitor Gives Rise to Pituitary Adenomas. Genes Cancer (2010) 0.99
Rb1 gene inactivation expands satellite cell and postnatal myoblast pools. J Biol Chem (2011) 0.96
Near-infrared imaging of injured tissue in living subjects using IR-820. Mol Imaging (2009) 0.95
Cross-species array comparative genomic hybridization identifies novel oncogenic events in zebrafish and human embryonal rhabdomyosarcoma. PLoS Genet (2013) 0.94
IGF-1 receptor inhibition by picropodophyllin in medulloblastoma. Biochem Biophys Res Commun (2010) 0.93
Myf5 expression during fetal myogenesis defines the developmental progenitors of adult satellite cells. Dev Biol (2013) 0.93
High-throughput detection of glutathione s-transferase polymorphic alleles in a pediatric cancer population. Cancer Epidemiol Biomarkers Prev (2004) 0.92
Functional evaluation of therapeutic response for a mouse model of medulloblastoma. Transgenic Res (2010) 0.92
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med (2015) 0.91
Low-grade myofibrosarcoma of the head and neck: importance of surgical therapy. J Pediatr Hematol Oncol (2004) 0.91
IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma. Clin Cancer Res (2011) 0.91
Brief report: Blockade of Notch signaling in muscle stem cells causes muscular dystrophic phenotype and impaired muscle regeneration. Stem Cells (2013) 0.90
CCAAT/enhancer binding protein beta is expressed in satellite cells and controls myogenesis. Stem Cells (2012) 0.90
Optimization of volumetric computed tomography for skeletal analysis of model genetic organisms. Anat Rec (Hoboken) (2008) 0.90
Evaluation of the effect of routine histologic processing on the size of skin samples obtained from dogs. Am J Vet Res (2005) 0.88
The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro. BMC Vet Res (2013) 0.87
The clinical, research, and social value of autopsy after any cancer death: a perspective from the Children's Oncology Group Soft Tissue Sarcoma Committee. Cancer (2011) 0.87
AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell. Cell Cycle (2012) 0.86
A case study of personalized therapy for osteosarcoma. Pediatr Blood Cancer (2013) 0.86
Bortezomib stabilizes NOXA and triggers ROS-associated apoptosis in medulloblastoma. J Neurooncol (2011) 0.86
Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar Rhabdomyosarcoma. Mol Cancer Res (2013) 0.84
Developmental origins of fusion-negative rhabdomyosarcomas. Curr Top Dev Biol (2011) 0.83
Multimodality Chamber for coregistered anatomical and molecular imaging of small animals. Lab Anim (NY) (2007) 0.83
Boolean network inference from time series data incorporating prior biological knowledge. BMC Genomics (2012) 0.83
MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma. Sarcoma (2013) 0.83
Contrast enhanced vessel imaging using microCT. J Vis Exp (2011) 0.83
CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells. Int J Cancer (2012) 0.83
Adaptive intervention in probabilistic boolean networks. Bioinformatics (2009) 0.83
Small molecule inhibition of PAX3-FOXO1 through AKT activation suppresses malignant phenotypes of alveolar rhabdomyosarcoma. Mol Cancer Ther (2013) 0.82
An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcoma. Biochem Biophys Res Commun (2012) 0.82
Thermal windows on Brazilian free-tailed bats facilitate thermoregulation during prolonged flight. Integr Comp Biol (2010) 0.82
Biomechanical comparison of cortical radial graft versus ulnar transposition graft limb-sparing techniques for the distal radial site in dogs. Vet Surg (2004) 0.82
Frequent alteration of the tumor suppressor gene APC in sporadic canine colorectal tumors. PLoS One (2012) 0.81
Comparative non-cholinergic neurotoxic effects of paraoxon and diisopropyl fluorophosphate (DFP) on human neuroblastoma and astrocytoma cell lines. Toxicol Appl Pharmacol (2006) 0.81
Severe runting in a laboratory mouse (Mus musculus). Lab Anim (NY) (2007) 0.81
The not-so-skinny on muscle cancer. Cancer Cell (2012) 0.81
PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma. Proc Natl Acad Sci U S A (2014) 0.81
IL-4 receptor blockade abrogates satellite cell: rhabdomyosarcoma fusion and prevents tumor establishment. Stem Cells (2013) 0.80
Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model. Sarcoma (2011) 0.79
Microscopic computed tomography-based virtual histology of embryos. Methods Mol Biol (2014) 0.78
Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model. J Pediatr Hematol Oncol (2012) 0.78
An Integrated Approach to Anti-Cancer Drug Sensitivity Prediction. IEEE/ACM Trans Comput Biol Bioinform (2015) 0.78
18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models. Pediatr Blood Cancer (2012) 0.78
Feasibility of labile Zn phytoextraction using enhanced tobacco and sunflower: results of five- and one-year field-scale experiments in Switzerland. Int J Phytoremediation (2014) 0.78
Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma. J Exp Clin Cancer Res (2013) 0.77
Utilizing signature-score to identify oncogenic pathways of cholangiocarcinoma. Transl Cancer Res (2013) 0.77
Refinement of a morphological scoring system for postimplantation rabbit conceptuses. Birth Defects Res B Dev Reprod Toxicol (2007) 0.76
Craniorachischisis and omphalocele in a stillborn cynomolgus monkey (Macaca fascicularis). Am J Med Genet A (2011) 0.75
Integrin-linked kinase: both Jekyll and Hyde in rhabdomyosarcoma. J Clin Invest (2009) 0.75
Crimson carrier, a long-acting contrast agent for in vivo near-infrared imaging of injured and diseased muscle. Muscle Nerve (2010) 0.75
Renal stem cell biology starts to take spherical shape. Commentary on: Lusis et al., Isolation of clonogenic, long-term self renewing embryonic renal stem cells. Stem Cell Res (2010) 0.75
The long road to immunotherapy for childhood rhabdomyosarcoma. Pediatr Blood Cancer (2011) 0.75
Personalized cancer care: opportunities and challenges in pediatric neuro-oncology. Pediatr Blood Cancer (2011) 0.75
Vascular contrast enhanced micro-CT imaging of "radiators" in the Brazilian free-tailed bat (Tadarida brasiliensis). Anat Rec (Hoboken) (2012) 0.75
What is your diagnosis? Peritoneal fluid from a 1-year-old female German Shepherd dog. Malignant teratoma. Vet Clin Pathol (2010) 0.75
Gesture recognition for smart home applications using portable radar sensors. Conf Proc IEEE Eng Med Biol Soc (2014) 0.75
Non-contact multi-radar smart probing of body orientation based on micro-Doppler signatures. Conf Proc IEEE Eng Med Biol Soc (2014) 0.75
Prognosis for dogs with stage III osteosarcoma following treatment with amputation and chemotherapy with and without metastasectomy. J Am Vet Med Assoc (2017) 0.75
Effects of topical application of taurolidine on second intention healing of experimentally induced wounds in rats. Am J Vet Res (2008) 0.75
Generation of intervention strategy for a genetic regulatory network represented by a family of Markov Chains. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75
Microscopic computed tomography-based skeletal phenotyping for genetic model organisms. Methods Mol Biol (2014) 0.75